Research areas
Novartis Phase 3 Trial Fails for Lp(a) Drug Pelacarsen
Novartis's pelacarsen, an antisense drug developed with Ionis to lower lipoprotein(a), did not reduce major cardiovascular events in high-risk patients.
#Cardiovascular
Every Medical Research story tagged Cardiovascular.
Research areas
Lancet Series calls for reimagined maternal cardiovascular care
A new Lancet Series argues that cardiovascular care in pregnancy must shift from reacting to crises to anticipating and managing long-term risk.
Research areas
DOACs Win First Trial for Lower-Risk Afib
The SINGLE-AF trial found direct oral anticoagulants reduced cardiovascular events in atrial fibrillation patients with a single stroke risk factor.